Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-33–mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury
Quan Liu, Gaelen K. Dwyer, Yifei Zhao, Huihua Li, Lisa R. Mathews, Anish Bhaswanth Chakka, Uma R. Chandran, Jake A. Demetris, John F. Alcorn, Keven M. Robinson, Luis A. Ortiz, Bruce R. Pitt, Angus W. Thomson, Ming-Hui Fan, Timothy R. Billiar, Hēth R. Turnquist
Quan Liu, Gaelen K. Dwyer, Yifei Zhao, Huihua Li, Lisa R. Mathews, Anish Bhaswanth Chakka, Uma R. Chandran, Jake A. Demetris, John F. Alcorn, Keven M. Robinson, Luis A. Ortiz, Bruce R. Pitt, Angus W. Thomson, Ming-Hui Fan, Timothy R. Billiar, Hēth R. Turnquist
View: Text | PDF
Research Article Immunology Pulmonology

IL-33–mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury

  • Text
  • PDF
Abstract

Acute respiratory distress syndrome is an often fatal disease that develops after acute lung injury and trauma. How released tissue damage signals, or alarmins, orchestrate early inflammatory events is poorly understood. Herein we reveal that IL-33, an alarmin sequestered in the lung epithelium, is required to limit inflammation after injury due to an unappreciated capacity to mediate Foxp3+ Treg control of local cytokines and myeloid populations. Specifically, Il33–/– mice are more susceptible to lung damage–associated morbidity and mortality that is typified by augmented levels of the proinflammatory cytokines and Ly6Chi monocytes in the bronchoalveolar lavage fluid. Local delivery of IL-33 at the time of injury is protective but requires the presence of Treg cells. IL-33 stimulates both mouse and human Tregs to secrete IL-13. Using Foxp3Cre × Il4/Il13fl/fl mice, we show that Treg expression of IL-13 is required to prevent mortality after acute lung injury by controlling local levels of G-CSF, IL-6, and MCP-1 and inhibiting accumulation of Ly6Chi monocytes. Our study identifies a regulatory mechanism involving IL-33 and Treg secretion of IL-13 in response to tissue damage that is instrumental in limiting local inflammatory responses and may shape the myeloid compartment after lung injury.

Authors

Quan Liu, Gaelen K. Dwyer, Yifei Zhao, Huihua Li, Lisa R. Mathews, Anish Bhaswanth Chakka, Uma R. Chandran, Jake A. Demetris, John F. Alcorn, Keven M. Robinson, Luis A. Ortiz, Bruce R. Pitt, Angus W. Thomson, Ming-Hui Fan, Timothy R. Billiar, Hēth R. Turnquist

×

Figure 5

IL-33 expands suppressive human Tregs that secrete IL-13.

Options: View larger image (or click on image) Download as PowerPoint
IL-33 expands suppressive human Tregs that secrete IL-13.
(A–D) Human Tr...
(A–D) Human Tregs (CD4+CD25hiCD127lo) sorted from peripheral blood mononuclear cells (PBMCs) were cultured with allogeneic monocyte-derived dendritic cells (Mono-DCs) and recombinant human IL-2 (300 U/ml) alone or with recombinant human IL-33 (50 ng/ml) added. (A) Cells were counted on the seventh day of culture and mean ± SD fold increase in Tregs depicted. Data represent 8 individual experiments with 18 different Treg and Mono-DC combinations. (B) Ex vivo–expanded Tregs from each culture condition were tested for their ability to suppress Teff proliferative responses to CD40L-activated allogeneic B cells. Treg suppressive function is expressed as percentage suppression of T cell proliferation and the mean ± SD from 5 cultures of expanded Tregs are depicted. (C and D) Supernatants were harvested on day 7 of culture and assessed by Cytometric Bead Array (CBA) for (C) IL-10 and (D) IL-13. Data depicted are the mean ± SD. (E) Mean frequency of IL-13+CD4+Foxp3hi cells in cultures with and without IL-33 was determined by intracellular IL-13 and Foxp3 staining of one donor’s Tregs following 7 days of culture with Mono-DCs generated from 2 different donors. Data depict Tregs from 3 different donors and are the mean ± SEM. Statistical significance was determined between each condition by unpaired, 2-tailed Student’s t test. *P < 0.01, **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts